Sinotherapeutics Inc. (688247.SH): SGLT2 Metformin Extended-Release Tablets Approved by the U.S. FDA.

Sinotherapeutics Inc. (688247.SH) announced that the company has received a notification from the US Food and Drug Administration (FDA) that its abbreviated new drug application (ANDA) for Sitagliptin Metformin Extended-Release Tablets has received temporary approval. The Sitagliptin Metformin Extended-Release Tablets, developed by MERCK SHARPDOHME, were approved for sale in the United States in February 2012, and are used to improve blood sugar control in adults with type 2 diabetes.